Literature DB >> 25028089

Discovering a vaccine against neosporosis using computers: is it feasible?

Stephen J Goodswen1, Paul J Kennedy2, John T Ellis3.   

Abstract

A vaccine is urgently needed to prevent cattle neosporosis. This infectious disease is caused by the parasite Neospora caninum, a complex biological system with multifaceted life cycles. An in silico vaccine discovery approach attempts to transform digital abstractions of this system into adequate knowledge to predict candidates. Researchers need current information to implement such an approach, such as understanding evasion mechanisms of the immune system, type of immune response to elicit, availability of data and prediction programs, and statistical models to analyze predictions. Taken together, an in silico approach involves assembly of an intricate jigsaw of interdisciplinary and interdependent knowledge. In this review, we focus on the approach influencing vaccine development against Neospora caninum, which can be generalized to other pathogenic apicomplexans.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Apicomplexa; Neospora caninum; in silico vaccine discovery; neosporosis; reverse vaccinology; vaccinomics

Mesh:

Substances:

Year:  2014        PMID: 25028089     DOI: 10.1016/j.pt.2014.06.004

Source DB:  PubMed          Journal:  Trends Parasitol        ISSN: 1471-4922


  8 in total

1.  Towards the First Multiepitope Vaccine Candidate against Neospora caninum in Mouse Model: Immunoinformatic Standpoint.

Authors:  Morteza Shams; Bahman Maleki; Bahareh Kordi; Hamidreza Majidiani; Naser Nazari; Hamid Irannejad; Ali Asghari
Journal:  Biomed Res Int       Date:  2022-06-09       Impact factor: 3.246

2.  Determination of B and T Cell Epitopes in Neospora caninum Immune Mapped Protein-1 (IMP-1): Implications in Vaccine Design against Neosporosis.

Authors:  Naser Nazari; Bahareh Kordi; Bahman Maleki; Morteza Shams; Esfandiar Azizi; Hamidreza Majidiani; Razi Naserifar
Journal:  Biomed Res Int       Date:  2022-04-07       Impact factor: 3.411

3.  The genome of the protozoan parasite Cystoisospora suis and a reverse vaccinology approach to identify vaccine candidates.

Authors:  Nicola Palmieri; Aruna Shrestha; Bärbel Ruttkowski; Tomas Beck; Claus Vogl; Fiona Tomley; Damer P Blake; Anja Joachim
Journal:  Int J Parasitol       Date:  2017-02-02       Impact factor: 3.981

4.  Neospora caninum SRS2 Protein: Essential Vaccination Targets and Biochemical Features for Next-Generation Vaccine Design.

Authors:  Ali Asghari; Bahareh Kordi; Bahman Maleki; Hamidreza Majidiani; Morteza Shams; Razi Naserifar
Journal:  Biomed Res Int       Date:  2022-04-06       Impact factor: 3.411

5.  Predominant role of interferon-γ in the host protective effect of CD8(+) T cells against Neospora caninum infection.

Authors:  Alexandra Correia; Pedro Ferreirinha; Sofia Botelho; Ana Belinha; Catarina Leitão; Íris Caramalho; Luzia Teixeira; África González-Fernandéz; Rui Appelberg; Manuel Vilanova
Journal:  Sci Rep       Date:  2015-10-09       Impact factor: 4.379

Review 6.  Cystoisospora suis - A Model of Mammalian Cystoisosporosis.

Authors:  Aruna Shrestha; Ahmed Abd-Elfattah; Barbara Freudenschuss; Barbara Hinney; Nicola Palmieri; Bärbel Ruttkowski; Anja Joachim
Journal:  Front Vet Sci       Date:  2015-11-30

Review 7.  Vaccines Meet Big Data: State-of-the-Art and Future Prospects. From the Classical 3Is ("Isolate-Inactivate-Inject") Vaccinology 1.0 to Vaccinology 3.0, Vaccinomics, and Beyond: A Historical Overview.

Authors:  Nicola Luigi Bragazzi; Vincenza Gianfredi; Milena Villarini; Roberto Rosselli; Ahmed Nasr; Amr Hussein; Mariano Martini; Masoud Behzadifar
Journal:  Front Public Health       Date:  2018-03-05

8.  Computational MHC-I epitope predictor identifies 95% of experimentally mapped HIV-1 clade A and D epitopes in a Ugandan cohort.

Authors:  Daniel Lule Bugembe; Andrew Obuku Ekii; Nicaise Ndembi; Jennifer Serwanga; Pontiano Kaleebu; Pietro Pala
Journal:  BMC Infect Dis       Date:  2020-02-22       Impact factor: 3.090

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.